Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcloxa is an aluminum salt of allantoin, chemically known as aluminum chlorohydroxyallantoinate. It combines the astringent and mild antimicrobial properties of aluminum compounds with the soothing, healing, keratolytic, and anti-irritant effects of allantoin. Alcloxa acts primarily as an antiperspirant by reducing sweat production through swelling and plugging of sweat gland ducts. Its bacteriostatic action provides deodorizing effects by inhibiting bacterial growth via reduced water availability and direct antimicrobial activity from the aluminum component. The compound is well tolerated compared to other aluminum salts due to the presence of allantoin, which minimizes irritation. Alcloxa is used in a variety of over-the-counter topical products for conditions such as minor skin irritations (including eczema), acne, foot odor control, diaper rash, hemorrhoids (as a keratolytic agent), and oral care for sensitive teeth or gum disease[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alcloxa.